Kreitzer Anatol: insider trades.
Kreitzer Anatol reported 8 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 7 sales ($1.3M), across 1 company.
- Transactions
- 8
- Purchases (P)
- 0
- Sales (S)
- 7
- Companies
- 1
- Name as filed
- Kreitzer Anatol
Companies
| Company | Relationship | Transactions |
|---|---|---|
| MapLight Therapeutics, Inc. (MPLT) | Officer · Chief Discovery Officer | 8 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-17 | MapLight Therapeutics, Inc. | A | 6,020 | $0 | 180,926 | Form 4 |
| 2026-07-17 | MapLight Therapeutics, Inc. | S | 200 | $38.39 | 174,906 | Form 4 |
| 2026-07-17 | MapLight Therapeutics, Inc. | S | 14,140 | $37.7 | 175,106 | Form 4 |
| 2026-07-17 | MapLight Therapeutics, Inc. | S | 2,833 | $37.05 | 189,246 | Form 4 |
| 2026-07-16 | MapLight Therapeutics, Inc. | S | 1,592 | $37.44 | 192,079 | Form 4 |
| 2026-07-16 | MapLight Therapeutics, Inc. | S | 7,464 | $36.66 | 193,671 | Form 4 |
| 2026-07-15 | MapLight Therapeutics, Inc. | S | 4,510 | $36.94 | 201,135 | Form 4 |
| 2026-07-15 | MapLight Therapeutics, Inc. | S | 5,545 | $36.13 | 205,645 | Form 4 |
Questions
What stock did Kreitzer Anatol buy or sell?
Kreitzer Anatol reported 8 non-derivative transactions on 2 SEC ownership filings in Q3 2026: 0 open-market purchases and 7 sales ($1.3M), across 1 company.
Is Kreitzer Anatol the same person as other filers with this name?
This page covers SEC CIK 2021238 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/kreitzer-anatol-2021238.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.